The pharmaceutical industry is rapidly evolving, with substantial demand for high-performance Active Pharmaceutical Ingredients (APIs). Dulaglutide, a diabetes drug, represents example of this trend. To fulfill this demand, US-based manufacturing services are emerging. These organizations offer a